Last updated on February 2017

Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation


Brief description of study

The purpose of this study is to see how well transfusions of T-cells work in treating CMV. Tcells are a type of white blood cell that helps protect the body from infection. A transfusion is the process by which blood from one person is transferred to the blood of another. In this case, the T-cells are made from the blood of donors who are immune to CMV. The T-cells are then grown and taught to attack the CMV virus in a lab.

Clinical Study Identifier: NCT02136797

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Susan Prockop, MD

Memorial Sloan Kettering Cancer Center
New York, NY United States
  Connect »